European Archives - Page 160 of 1054 - European Medical Journal

Can Digital Interventions Improve Influenza Vaccination Rates?

A study in Denmark found that digital letters boosted flu vaccination rates among seniors, especially those who skipped the previous season.

Psychiatric Disorders Influence COVID-19 and Influenza Vaccine Uptake

A recent study found that individuals with psychiatric disorders were more likely to get flu vaccines but less likely to receive COVID-19 vaccines.

Tailored Radiotherapy Reduces Treatment Margins for Gastric Lymphoma

A study on online adaptive radiotherapy reveals reduced treatment margins and lower radiation doses to organs at risk in gastric MALT lymphoma patients

Machine Learning Tool Detects Pulmonary Oedema

New research shows changes in haemoglobin levels can accurately detect hydrostatic pulmonary oedema in patients with acute dyspnoea

Impact of Low Radiation on Blood Cancer Rates

The latest update to the INWORKS study enhances the understanding of the link between low-dose ionising radiation and mortality from haematological malignancies

Lifestyle Changes Help Counteract Diabetes-Induced Brain Ageing

Diabetes has long been recognised as a risk factor for dementia, but new research reveals its connection to accelerated brain ageing

Understanding the Risk Factors for Anaemia in Adults with HIV

A large proportion of adults living with HIV have been found to have anaemia, with several risk factors contributing to its prevalence, according to recent research.

High Pulse Pressure Linked to Kidney Failure Risk in Patients with Diabetes

A recent study highlighting the impact of high pulse pressure on kidney outcomes in diabetic patients.

High-Dose Haemodiafiltration Boosts Survival and Quality of Life

A recent trial aimed to identify the best possible dialysis treatment by comparing high-dose haemodiafiltration versus conventional high-flux haemodialysis

Illustration of man administering vaccine to a woman

GSK pursues co-administration of RSV and shingles vaccines

New findings have been revealed on the co-administration of GSK’s RSV and existing shingles vaccine.